eXoZymes Inc. Common Stock EXOZ Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| —— | —— | —— | —— | —— | ||
| $1.12M+0.8% | $1.11M-8.6% | $1.22M+51.5% | $802.99K+39.6% | $575.02K-8.8% | ||
| $1.27M-20.0% | $1.58M+21.3% | $1.31M-25.2% | $1.75M+26.8% | $1.38M+1.7% | ||
| $2.39M-11.4% | $2.7M+6.9% | $2.52M-1.0% | $2.55M+30.6% | $1.95M-1.6% | ||
| -$2.39M+11.4% | -$2.7M-6.9% | -$2.52M+1.0% | -$2.55M-30.6% | -$1.95M+1.6% | ||
| $13.72K-89.6% | $132.04K+123% | $59.19K-22.7% | $76.56K-18.8% | $94.31K+2,863% | ||
| $3.01K— | —— | $176.03K+58.3% | $111.2K— | —— | ||
| -$2.37M+14.1% | -$2.76M-20.7% | -$2.29M+3.1% | -$2.36M-27.1% | -$1.86M-1.0% | ||
| —— | -$26.3K0.0% | -$26.3K0.0% | -$26.3K0.0% | -$26.3K— | ||
| -$2.37M+10.7% | -$2.66M-16.1% | -$2.29M+3.1% | -$2.36M-27.1% | -$1.86M-1.1% | ||
| -$0.28+9.7% | -$0.31-14.8% | -$0.27+3.6% | -$0.28-27.3% | -$0.22+12.0% | ||
| -$2.31M+11.8% | -$2.62M-7.0% | -$2.45M+1.0% | -$2.48M-31.7% | -$1.88M+1.9% | ||
| -$2.39M+11.4% | -$2.7M-6.9% | -$2.52M+1.0% | -$2.55M-30.6% | -$1.95M+1.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is eXoZymes Inc. Common Stock's revenue?
- eXoZymes Inc. Common Stock (EXOZ) generated $70.1K in revenue over the trailing twelve months.
- Is eXoZymes Inc. Common Stock profitable?
- eXoZymes Inc. Common Stock is not currently profitable: it reported a net loss of $9.7M over the trailing twelve months, a -2909.1% net margin.
- What is eXoZymes Inc. Common Stock's earnings per share?
- eXoZymes Inc. Common Stock's diluted EPS over the trailing twelve months is $-1.14.
- Where does eXoZymes Inc. Common Stock's income statement data come from?
- Every line is extracted from eXoZymes Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
